Company News For Sep 13, 2018

Zacks Equity Research Published on September 13, 2018

Gilead Sciences, Inc.’s (GILD - Free Report) shares gained 2.4% after the company saw encouraging results for an experimental rheumatoid arthritis in a phase 3 study.
Shares of Verizon Communications Inc. (VZ - Free Report) increased 0.5% on news that the company was launching next-generation 5G services in four cities, viz., Los Angeles, Houston, Indianapolis and Sacramento, in October
Bausch Health Companies Inc.’s (BHC - Free Report) shares surged 13.9% after the company reached an agreement in a patent dispute over a treatment for irritable bowel syndrome
Shares of Wabco Holdings Inc. declined 5.9% after the company said that it now expects 2018 adjusted earnings per share to be in the lower half of previously provided guidance of $7.45 to $7.70 per share

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.